1-20 of 6351
Journal Articles
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Modified albumin-bilirubin grade and alpha-fetoprotein score for predicting prognosis of hepatocellular carcinoma patients undergoing conventional transarterial chemoembolization

Available to Purchase
Subject Area:
Oncology
Manabu Hayashi, Kazumichi Abe, Tatsuro Sugaya, Naoto Abe, Yosuke Takahata, Masashi Fujita, Hiromasa Ohira
Journal: Oncology
Oncology (2025)
https://doi.org/10.1159/000546334
Published Online: 10 May 2025
View articletitled, Modified albumin-bilirubin grade and alpha-fetoprotein score for predicting prognosis of hepatocellular carcinoma patients undergoing conventional transarterial chemoembolization
Open the PDF for Modified albumin-bilirubin grade and alpha-fetoprotein score for predicting prognosis of hepatocellular carcinoma patients undergoing conventional transarterial chemoembolization in another window
Journal Articles

Efficacy of locoregional treatment for oligo-drug-resistant lesions during first-line atezolizumab plus bevacizumab therapy for unresectable hepatocellular carcinoma: a single-center retrospective study

Available to Purchase
Subject Area:
Oncology
Tasuku Nakabori, Sena Higashi, Kaori Mukai, Toshiki Ikawa, Noboru Maeda, Masaki Kawabata, Kana Hosokawa, Kazuhiro Kozumi, Makiko Urabe, Yugo Kai, Ryoji Takada, Kenji Ikezawa, Koji Konishi, Katsuyuki Nakanishi, Kazuyoshi Ohkawa
Journal: Oncology
Oncology (2025)
https://doi.org/10.1159/000546211
Published Online: 02 May 2025
View articletitled, Efficacy of locoregional treatment for oligo-drug-resistant lesions during first-line atezolizumab plus bevacizumab therapy for unresectable hepatocellular carcinoma: a single-center retrospective study
Open the PDF for Efficacy of locoregional treatment for oligo-drug-resistant lesions during first-line atezolizumab plus bevacizumab therapy for unresectable hepatocellular carcinoma: a single-center retrospective study in another window
Journal Articles

The Know-how Post-transplant Skin cancer for Immunotherapy and target therapies

Available to Purchase
Subject Area:
Oncology
Nerina Denaro, Emanuela Passoni, Giulia Murgia, Cinzia Solinas, Gianluca Nazzaro, Angelo Valerio Marzano, Maria Rosaria Campise, Ornella Garrone
Journal: Oncology
Oncology (2025)
https://doi.org/10.1159/000543801
Published Online: 29 April 2025
View articletitled, The Know-how Post-transplant Skin cancer for Immunotherapy and target therapies
Open the PDF for The Know-how Post-transplant Skin cancer for Immunotherapy and target therapies in another window
Journal Articles

Erratum - Alternative Palbociclib Dosing Schedules for Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer

Free
Subject Area:
Oncology
Journal: Oncology
Oncology 548.
https://doi.org/10.1159/000545399
Published Online: 28 April 2025
View articletitled, Erratum - Alternative Palbociclib Dosing Schedules for Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer
Open the PDF for Erratum - Alternative Palbociclib Dosing Schedules for Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer in another window
Journal Articles

Determining the cut-off value of the MASCC Score to predict mortality in hospitalized febrile neutropenic patients: A decade-long single-center retrospective cohort study

Available to Purchase
Subject Area:
Oncology
Yasemin Nadir, Pinar Kiran, Damla Erturk, Hale Bulbul, Mustafa Degirmenci, Suheyla Senger
Journal: Oncology
Oncology (2025)
https://doi.org/10.1159/000546029
Published Online: 24 April 2025
View articletitled, Determining the cut-off value of the MASCC Score to predict mortality in hospitalized febrile neutropenic patients: A decade-long single-center retrospective cohort study
Open the PDF for Determining the cut-off value of the MASCC Score to predict mortality in hospitalized febrile neutropenic patients: A decade-long single-center retrospective cohort study in another window
Journal Articles

Prognostic impact of recurrence pattern for surgically resected non-small cell lung cancer

Available to Purchase
Subject Area:
Oncology
Nozomu Motono, Takaki Mizoguchi, Masahito Ishikawa, Shun Iwai, Yoshihito Iijima, Hidetaka Uramoto
Journal: Oncology
Oncology (2025)
https://doi.org/10.1159/000545310
Published Online: 24 April 2025
View articletitled, Prognostic impact of recurrence pattern for surgically resected non-small cell lung cancer
Open the PDF for Prognostic impact of recurrence pattern for surgically resected non-small cell lung cancer in another window
Journal Articles

Patient-reported outcome-based symptom management improves QoL in postoperative gastroesophageal cancer patients: A Randomized Controlled Trial

Available to Purchase
Subject Area:
Oncology
Shusheng Wu, Jiayu Niu, Conglan Ding, Lihong Ke, Mengge Li, Ying Yan, Huijun Xu, Xiaoxiu Hu, Wenju Chen, Huiqin Luo, Liyuan Fan, Huimin Li, Lulu Cao, Yifu He
Journal: Oncology
Oncology (2025)
https://doi.org/10.1159/000545529
Published Online: 10 April 2025
View articletitled, Patient-reported outcome-based symptom management improves QoL in postoperative gastroesophageal cancer patients: A Randomized Controlled Trial
Open the PDF for Patient-reported outcome-based symptom management improves QoL in postoperative gastroesophageal cancer patients: A Randomized Controlled Trial in another window
Journal Articles

Factors relating to Tumor size and survival in patients with hepatocellular carcinoma: significance of PLR, PVT and albumin.

Available to Purchase
Subject Area:
Oncology
Rossella Donghia, Brian Irving Carr, Sezai Yilmaz
Journal: Oncology
Oncology (2025)
https://doi.org/10.1159/000545636
Published Online: 08 April 2025
View articletitled, Factors relating to Tumor size and survival in patients with hepatocellular carcinoma: significance of PLR, PVT and albumin.
Open the PDF for Factors relating to Tumor size and survival in patients with hepatocellular carcinoma: significance of PLR, PVT and albumin. in another window
Journal Articles

The Effectiveness of Long-Term Continuation of Atezolizumab plus Bevacizumab in Patients Receiving Systemic Chemotherapy for Advanced Hepatocellular Carcinoma: A Multicenter Study

Available to Purchase
Subject Area:
Oncology
Takanori Suzuki, Kiyoto Narita, Kentaro Matsuura, Daisuke Kato, Katsumi Hayashi, Kohei Okayama, Fumihiro Okumura, Satoshi Sobue, Atsunori Kusakabe, Izumi Hasegawa, Tsutomu Mizoshita, Yoshihide Kimura, Hiromu Kondo, Atsushi Ozasa, Hayato Kawamura, Kei Fujiwara, Shunsuke Nojiri, Hiromi Kataoka, Sakurayama Liver Study Group (SLSG)
Journal: Oncology
Oncology (2025)
https://doi.org/10.1159/000544051
Published Online: 28 March 2025
View articletitled, The Effectiveness of Long-Term Continuation of Atezolizumab plus Bevacizumab in Patients Receiving Systemic Chemotherapy for Advanced Hepatocellular Carcinoma: A Multicenter Study
Open the PDF for The Effectiveness of Long-Term Continuation of Atezolizumab plus Bevacizumab in Patients Receiving Systemic Chemotherapy for Advanced Hepatocellular Carcinoma: A Multicenter Study in another window
Journal Articles

Modified Glasgow Prognostic Score as a Marker for Predicting Outcomes in Patients with either Bladder or Prostate Cancer: A Systematic Review and Meta-Analysis

Available to Purchase
Subject Area:
Oncology
Jie Chen, Suna Fu, Jianhong Yu, Qi Tang, Xiuping Wu, Sai Luo, Huifang Sun
Journal: Oncology
Oncology (2025)
https://doi.org/10.1159/000545001
Published Online: 28 March 2025
View articletitled, Modified Glasgow Prognostic Score as a Marker for Predicting Outcomes in Patients with either Bladder or Prostate Cancer: A Systematic Review and Meta-Analysis
Open the PDF for Modified Glasgow Prognostic Score as a Marker for Predicting Outcomes in Patients with either Bladder or Prostate Cancer: A Systematic Review and Meta-Analysis in another window
Journal Articles

Impact of Social Vulnerability Index on Multiple Myeloma Mortality

Available to Purchase
Subject Area:
Oncology
Jia Yi Tan, Boon Jian San, Tze Ern Ong, Yong Hao Yeo, Modupe Idowu
Journal: Oncology
Oncology (2025)
https://doi.org/10.1159/000545459
Published Online: 28 March 2025
View articletitled, Impact of Social Vulnerability Index on Multiple Myeloma Mortality
Open the PDF for Impact of Social Vulnerability Index on Multiple Myeloma Mortality in another window
Journal Articles

Changes in Tumor-Infiltrating Lymphocytes and Inflammatory Blood Factors during Chemoradiation Therapy in Rectal Cancer

Available to Purchase
Subject Area:
Oncology
Hiroshi Miyakita, Takashi Ogimi, Hajime Kayano, Masaki Mori, Seiichiro Yamamoto
Journal: Oncology
Oncology (2025)
https://doi.org/10.1159/000545312
Published Online: 28 March 2025
View articletitled, Changes in Tumor-Infiltrating Lymphocytes and Inflammatory Blood Factors during Chemoradiation Therapy in Rectal Cancer
Open the PDF for Changes in Tumor-Infiltrating Lymphocytes and Inflammatory Blood Factors during Chemoradiation Therapy in Rectal Cancer in another window
Journal Articles

Mechanism and Application Prospect of Noncoding RNA Regulating Tumor Cell Pyroptosis

Available to Purchase
Subject Area:
Oncology
Wang Wan, Qiyang Mao, Zhuohong Ye, Dan Huang, Rongjing Zhang, Kangxian Wang, XueFeng Wang, QiaYu Wu, Zhu Liang, Chunyuan Chen
Journal: Oncology
Oncology (2025)
https://doi.org/10.1159/000543102
Published Online: 28 March 2025
View articletitled, Mechanism and Application Prospect of Noncoding RNA Regulating Tumor Cell Pyroptosis
Open the PDF for Mechanism and Application Prospect of Noncoding RNA Regulating Tumor Cell Pyroptosis in another window
Journal Articles

Cachexia Index as a Prognostic Indicator in Patients with Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy

Available to Purchase
Subject Area:
Oncology
Khanh Van Nguyen, Kosuke Matsui, Hisashi Kosaka, Hideyuki Matsushima, Hidekazu Yamamoto, Tung Thanh Lai, Kyoko Inoue, Moriyasu Takada, Fujimasa Tada, Atsushi Hiraoka, Takeshi Hatanaka, Toshifumi Tada, Takashi Kumada, Hiroki Kato, Kengo Yoshii, Takashi Yamaguchi, Shinji Shimoda, Makoto Naganuma, Masaki Kaibori
Journal: Oncology
Oncology (2025)
https://doi.org/10.1159/000544979
Published Online: 28 March 2025
View articletitled, Cachexia Index as a Prognostic Indicator in Patients with Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy
Open the PDF for Cachexia Index as a Prognostic Indicator in Patients with Unresectable Hepatocellular Carcinoma Receiving Atezolizumab and Bevacizumab Therapy in another window
Journal Articles

Antihistamines Improve the Survival of Lung Cancer: A 10-Year Cohort Study of Tertiary Hospital in Taiwan

Available to Purchase
Subject Area:
Oncology
Chun-Hsiang Hsu, Chiu-Fan Chen, Chun-Hao Yin, Yao-Shen Chen, Jin-Shuen Chen
Journal: Oncology
Oncology (2025)
https://doi.org/10.1159/000545458
Published Online: 28 March 2025
View articletitled, Antihistamines Improve the Survival of Lung Cancer: A 10-Year Cohort Study of Tertiary Hospital in Taiwan
Open the PDF for Antihistamines Improve the Survival of Lung Cancer: A 10-Year Cohort Study of Tertiary Hospital in Taiwan in another window
Journal Articles

Atezolizumab plus Bevacizumab Is Associated with Favorable Overall Survival over Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma

Available to Purchase
Subject Area:
Oncology
Hyung-Don Kim, Young-Gyu Park, Hyeyeon Hong, Sung Won Chung, Sejin Kim, Min-Hee Ryu, Baek-Yeol Ryoo, Jonggi Choi, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Han Chu Lee, Won-Mook Choi, Changhoon Yoo
Journal: Oncology
Oncology (2025)
https://doi.org/10.1159/000545351
Published Online: 21 March 2025
View articletitled, Atezolizumab plus Bevacizumab Is Associated with Favorable Overall Survival over Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma
Open the PDF for Atezolizumab plus Bevacizumab Is Associated with Favorable Overall Survival over Lenvatinib in Patients with Unresectable Hepatocellular Carcinoma in another window
Journal Articles

The Utility of the New Category by Number of Stations for Lymph Nodal Involvement in Non-Small Cell Lung Cancer

Available to Purchase
Subject Area:
Oncology
Nozomu Motono, Takaki Mizoguchi, Masahito Ishikawa, Shun Iwai, Yoshihito Iijima, Hidetaka Uramoto
Journal: Oncology
Oncology (2025)
https://doi.org/10.1159/000545002
Published Online: 21 March 2025
View articletitled, The Utility of the New Category by Number of Stations for Lymph Nodal Involvement in Non-Small Cell Lung Cancer
Open the PDF for The Utility of the New Category by Number of Stations for Lymph Nodal Involvement in Non-Small Cell Lung Cancer in another window
Journal Articles

Retraction Statement

Free
Subject Area:
Oncology
Journal: Oncology
Oncology 546–547.
https://doi.org/10.1159/000543881
Published Online: 20 March 2025
View articletitled, Retraction Statement
Open the PDF for Retraction Statement in another window
Journal Articles

Clinicopathological Significance of APC Mutation in Patient with Colorectal Cancer

Available to Purchase
Subject Area:
Oncology
Kyoung Min Kim, Woo Sung Moon, Gi Won Ha, Ho Sung Park, Kyu Yun Jang, Min Ro Lee, Myoung Ja Chung, Ae Ri Ahn
Journal: Oncology
Oncology (2025)
https://doi.org/10.1159/000545255
Published Online: 13 March 2025
View articletitled, Clinicopathological Significance of APC Mutation in Patient with Colorectal Cancer
Open the PDF for Clinicopathological Significance of APC Mutation in Patient with Colorectal Cancer in another window
Journal Articles

Prognostic Factors in Pleural Mesothelioma Patients Receiving First-Line Chemotherapy: Establishing the PLECH Baseline Risk Score

Open Access
Subject Area:
Oncology
Alberto Guijosa, Luis Antonio Cabrera-Miranda, Ana Pamela Gómez-García, Rogelio Trejo Rosales, Wendy Muñoz-Montaño, Diana Flores, Nancy Reynoso-Noverón, Oscar Arrieta
Journal: Oncology
Oncology (2025)
https://doi.org/10.1159/000543637
Published Online: 11 March 2025
View articletitled, Prognostic Factors in Pleural Mesothelioma Patients Receiving First-Line Chemotherapy: Establishing the PLECH Baseline Risk Score
Open the PDF for Prognostic Factors in Pleural Mesothelioma Patients Receiving First-Line Chemotherapy: Establishing the PLECH Baseline Risk Score in another window